LornoxicamThird Party Manufacturing in India

Lornoxicam works by inhibiting cyclooxygenase-1 and cyclooxygenase-2 enzymes concurrently. It inhibits prostaglandin synthesis to help the body eliminate severe pain, swelling, and localized inflammatory responses. Unlike older oxicams, it features a balanced short half-life that markedly reduces long-term systemic tissue accumulation and severe gastrointestinal side effects. It is highly effective and well-tolerated for managing high-intensity postoperative breakthrough pain.

Therapeutic Uses

• Postoperative Pain Management: Alleviates acute moderate to severe pain following orthopedic or general surgical treatments.
• Acute Rheumatoid Arthritis: Suppresses sudden inflammatory flares and restores mechanical joint mobility.

Why Manufacturers Choose Lornoxicam

Lornoxicam third party manufacturing in India represents a premium, high-margin asset within modern orthopedic and rheumatology pain management lines. Its clinical standing as a potent analgesic with low side effects makes it popular among modern healthcare professionals. Our partner manufacturing network employs modern freeze-drying or sterile liquid filling systems. Utilizing WHO-GMP certified partner facilities ensures that your brand delivers perfect therapeutic purity and maximum clinical efficacy.